Interferon therapy-induced reduction in PD-1 + CD8 + and CD160 + CD8 + T cells is associated with functional cure in hepatitis B

Peg-IFN-α may promote HBsAg clearance in selected HBeAg-negative patients with low antigen burden and partially reversible T-cell exhaustion.

Authors

Institutions

Publication Details

Journal
BMC Infectious Diseases
Published
2025-12-19
DOI
https://doi.org/10.1186/s12879-025-12042-7
Primary Topic
Hepatitis B Virus Studies
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Interferon therapy-induced reduction in PD-1 + CD8 + and CD160 + CD8 + T cells is associated with functional cure in hepatitis B

Jiangyu Liu, Ling Qin, Daqiong Zhou, Jianru Jia et al.
BMC Infectious Diseases
Hepatitis B Virus Studies
article

Interferon therapy-induced reduction in PD-1 + CD8 + and CD160 + CD8 + T cells is associated with functional cure in hepatitis B

Jiangyu Liu, Ling Qin, Daqiong Zhou, Jianru Jia, Hong Li, Zichen Zhang, Zhenhuan Cao
article en

Abstract

Peg-IFN-α may promote HBsAg clearance in selected HBeAg-negative patients with low antigen burden and partially reversible T-cell exhaustion.

BMC Infectious DiseasesVol. 25(1)
Capital Medical University (CN), Beijing YouAn Hospital (CN), Baoding People's Hospital (CN)
Openalex Percentile: Top 47%
Hepatitis B Virus Studies
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.